BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 34478583)

  • 1. The state of CD44 activation in cancer progression and therapeutic targeting.
    Guo Q; Yang C; Gao F
    FEBS J; 2022 Dec; 289(24):7970-7986. PubMed ID: 34478583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of Matrix Hyaluronan-Mediated CD44 Signaling, Epigenetic Regulation and Chemoresistance in Head and Neck Cancer Stem Cells.
    Bourguignon LYW; Earle C; Shiina M
    Int J Mol Sci; 2017 Aug; 18(9):. PubMed ID: 28837080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyaluronan-CD44 interaction promotes oncogenic signaling, microRNA functions, chemoresistance, and radiation resistance in cancer stem cells leading to tumor progression.
    Bourguignon LY; Shiina M; Li JJ
    Adv Cancer Res; 2014; 123():255-75. PubMed ID: 25081533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Novel Therapeutic siRNA Nanoparticle Designed for Dual-Targeting CD44 and Gli1 of Gastric Cancer Stem Cells.
    Yao H; Sun L; Li J; Zhou X; Li R; Shao R; Zhang Y; Li L
    Int J Nanomedicine; 2020; 15():7013-7034. PubMed ID: 33061365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer Cell CD44 Mediates Macrophage/Monocyte-Driven Regulation of Head and Neck Cancer Stem Cells.
    Gomez KE; Wu F; Keysar SB; Morton JJ; Miller B; Chimed TS; Le PN; Nieto C; Chowdhury FN; Tyagi A; Lyons TR; Young CD; Zhou H; Somerset HL; Wang XJ; Jimeno A
    Cancer Res; 2020 Oct; 80(19):4185-4198. PubMed ID: 32816856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD44 activation state regulated by the CD44v10 isoform determines breast cancer proliferation.
    Guo Q; Liu Y; He Y; Du Y; Zhang G; Yang C; Gao F
    Oncol Rep; 2021 Apr; 45(4):. PubMed ID: 33649828
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyaluronan-CD44 interaction promotes c-Src-mediated twist signaling, microRNA-10b expression, and RhoA/RhoC up-regulation, leading to Rho-kinase-associated cytoskeleton activation and breast tumor cell invasion.
    Bourguignon LY; Wong G; Earle C; Krueger K; Spevak CC
    J Biol Chem; 2010 Nov; 285(47):36721-35. PubMed ID: 20843787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Roles and targeting of the HAS/hyaluronan/CD44 molecular system in cancer.
    Karousou E; Misra S; Ghatak S; Dobra K; Götte M; Vigetti D; Passi A; Karamanos NK; Skandalis SS
    Matrix Biol; 2017 May; 59():3-22. PubMed ID: 27746219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyaluronan-CD44 interaction with leukemia-associated RhoGEF and epidermal growth factor receptor promotes Rho/Ras co-activation, phospholipase C epsilon-Ca2+ signaling, and cytoskeleton modification in head and neck squamous cell carcinoma cells.
    Bourguignon LY; Gilad E; Brightman A; Diedrich F; Singleton P
    J Biol Chem; 2006 May; 281(20):14026-40. PubMed ID: 16565089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stem cell marker (Nanog) and Stat-3 signaling promote MicroRNA-21 expression and chemoresistance in hyaluronan/CD44-activated head and neck squamous cell carcinoma cells.
    Bourguignon LY; Earle C; Wong G; Spevak CC; Krueger K
    Oncogene; 2012 Jan; 31(2):149-60. PubMed ID: 21685938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyaluronan-CD44 interaction promotes microRNA signaling and RhoGTPase activation leading to tumor progression.
    Bourguignon LY
    Small GTPases; 2012; 3(1):53-9. PubMed ID: 22714418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD44 interaction with Na+-H+ exchanger (NHE1) creates acidic microenvironments leading to hyaluronidase-2 and cathepsin B activation and breast tumor cell invasion.
    Bourguignon LY; Singleton PA; Diedrich F; Stern R; Gilad E
    J Biol Chem; 2004 Jun; 279(26):26991-7007. PubMed ID: 15090545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyaluronan-CD44 interaction with neural Wiskott-Aldrich syndrome protein (N-WASP) promotes actin polymerization and ErbB2 activation leading to beta-catenin nuclear translocation, transcriptional up-regulation, and cell migration in ovarian tumor cells.
    Bourguignon LY; Peyrollier K; Gilad E; Brightman A
    J Biol Chem; 2007 Jan; 282(2):1265-80. PubMed ID: 17092940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of hyaluronan-mediated CD44 signaling in head and neck squamous cell carcinoma progression and chemoresistance.
    Wang SJ; Bourguignon LY
    Am J Pathol; 2011 Mar; 178(3):956-63. PubMed ID: 21356346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyaluronan-CD44 interaction promotes HPV 16 E6 oncogene-mediated oropharyngeal cell carcinoma survival and chemoresistance.
    Bourguignon LYW; Earle C; Shiina M
    Matrix Biol; 2019 May; 78-79():180-200. PubMed ID: 30077625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyaluronan promotes signaling interaction between CD44 and the transforming growth factor beta receptor I in metastatic breast tumor cells.
    Bourguignon LY; Singleton PA; Zhu H; Zhou B
    J Biol Chem; 2002 Oct; 277(42):39703-12. PubMed ID: 12145287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyaluronic acid hydrogels with defined crosslink density for the efficient enrichment of breast cancer stem cells.
    Tan S; Yamashita A; Gao SJ; Kurisawa M
    Acta Biomater; 2019 Aug; 94():320-329. PubMed ID: 31125725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyaluronan-CD44 interaction promotes c-Jun signaling and miRNA21 expression leading to Bcl-2 expression and chemoresistance in breast cancer cells.
    Chen L; Bourguignon LY
    Mol Cancer; 2014 Mar; 13():52. PubMed ID: 24606718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyaluronan facilitates transforming growth factor-β1-dependent proliferation via CD44 and epidermal growth factor receptor interaction.
    Meran S; Luo DD; Simpson R; Martin J; Wells A; Steadman R; Phillips AO
    J Biol Chem; 2011 May; 286(20):17618-30. PubMed ID: 21454519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The CD147-HYALURONAN Axis in Cancer.
    Toole BP
    Anat Rec (Hoboken); 2020 Jun; 303(6):1573-1583. PubMed ID: 31090215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.